Combination Therapy of Imiquimod 5%Cream and Cryotherapy vs Monotherapy for Common Warts:Randomized Comparative Trial.

N/ANot Yet RecruitingNCT06973473

Assiut University60 enrolled

Overview

To assess the clinical efficacy and safety of topical imiquimod 5% cream combined with cryotherapy versus either of theme alone for the treatment of common warts by clinical and dermoscopic assessments.

Topical Imiquimod 5% cream Combined with Cryotherapy Versus either of them alone in Treatment of Common Warts: A prospective Randomized Comparative Trial

Study Type

OBSERVATIONAL

Enrollment

Conditions

Warts

Eligibility

Sex: ALLMin age: 18 YearsMax age: 60 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * Patients with common warts diagnosed clinically and by dermoscopy. * Patients older than 18years old. Exclusion Criteria: * Pregnancy and lactation. * Immunosuppression or being under any kind of treatment causing * absolute or relative immunosuppression. * Patients with chronic systemic diseases. * All cases of bleeding tendency or using anticoagulants. * Concurrent use of systemic or topical treatments of warts in the last 4 weeks.

Outcomes

Primary Outcomes

Complete clearance rate of common warts.

Assessment of complete warts clearance rate at 12weeks to evaluate the efficacy of combination therapy ( imiquimod5%cream+cryotherapy ) compared to topical imiquimod5%cream alone or cryotherapy alone in patients with common wart.

Time frame: 12 weeks

Central Contacts

Eman Fathy Ahmed Lecturer of Dermatology, Venereology and Andrology Faculty of

CONTACT

00201002258614 dr.emanfathy@aun.edu.eg

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.